NEOVOLTA INC(NASDAQ:NEOV) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 4 out of 10 to NEOV. NEOV was compared to 93 industry peers in the Electrical Equipment industry. No worries on liquidiy or solvency for NEOV as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, NEOV is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

NEOV had negative earnings in the past year.

In the past year NEOV has reported a negative cash flow from operations.

NEOV had negative earnings in each of the past 5 years.

In the past 5 years NEOV always reported negative operating cash flow.

1.2 Ratios

NEOV has a Return On Assets of -68.41%. This is amonst the worse of the industry: NEOV underperforms 81.32% of its industry peers.

NEOV has a worse Return On Equity (-72.87%) than 61.54% of its industry peers.

		Industry Rank	Sector Rank
ROA	-68.41%
ROE	-72.87%
ROIC	N/A

ROA(3y)-76.82%

ROA(5y)-101.61%

ROE(3y)-104.1%

ROE(5y)-119.8%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 19.51%, NEOV perfoms like the industry average, outperforming 47.25% of the companies in the same industry.

In the last couple of years the Gross Margin of NEOV has grown nicely.

NEOV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	19.51%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y12.68%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

NEOV has more shares outstanding than it did 1 year ago.

NEOV has more shares outstanding than it did 5 years ago.

NEOV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 343.88 indicates that NEOV is not in any danger for bankruptcy at the moment.

NEOV's Altman-Z score of 343.88 is amongst the best of the industry. NEOV outperforms 100.00% of its industry peers.

NEOV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	343.88

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

NEOV has a Current Ratio of 16.35. This indicates that NEOV is financially healthy and has no problem in meeting its short term obligations.

NEOV has a Current ratio of 16.35. This is amongst the best in the industry. NEOV outperforms 97.80% of its industry peers.

A Quick Ratio of 9.39 indicates that NEOV has no problem at all paying its short term obligations.

Looking at the Quick ratio, with a value of 9.39, NEOV belongs to the top of the industry, outperforming 95.60% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	16.35
Quick Ratio	9.39

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

NEOV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.04%.

NEOV shows a decrease in Revenue. In the last year, the revenue decreased by -7.79%.

Measured over the past years, NEOV shows a very negative growth in Revenue. The Revenue has been decreasing by -18.13% on average per year.

EPS 1Y (TTM)-22.04%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-190.1%

Revenue 1Y (TTM)-7.79%

Revenue growth 3Y-18.13%

Revenue growth 5YN/A

Sales Q2Q%-22.37%

3.2 Future

NEOV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.49% yearly.

The Revenue is expected to grow by 104.65% on average over the next years. This is a very strong growth

EPS Next Y-42.86%

EPS Next 2Y46.39%

EPS Next 3Y39.49%

EPS Next 5YN/A

Revenue Next Year71.43%

Revenue Next 2Y155.65%

Revenue Next 3Y104.65%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

NEOV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

NEOV is valuated quite expensively with a Price/Forward Earnings ratio of 408.82.

Based on the Price/Forward Earnings ratio, NEOV is valued a bit cheaper than the industry average as 62.64% of the companies are valued more expensively.

The average S&P500 Price/Forward Earnings ratio is at 24.11. NEOV is valued rather expensively when compared to this.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	408.82

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as NEOV's earnings are expected to grow with 39.49% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y46.39%

EPS Next 3Y39.49%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

NEOV does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

NEOVOLTA INC

NASDAQ:NEOV (1/17/2025, 8:17:18 PM)

After market: 4.11 -0.06 (-1.44%)

4.17

-0.29 (-6.5%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryElectrical Equipment

Earnings (Last)11-08 2024-11-08/amc

Earnings (Next)N/A N/A

Inst Owners4.76%

Inst Owner Change0%

Ins Owners14.84%

Ins Owner Change7.28%

Market Cap139.11M

Analysts82.86

Price Target7.65 (83.45%)

Short Float %3.09%

Short Ratio2.99

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-22.55%

Min EPS beat(2)-47.06%

Max EPS beat(2)1.96%

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-23.29%

Min Revenue beat(2)-27.7%

Max Revenue beat(2)-18.88%

Revenue beat(4)0

Avg Revenue beat(4)-51.01%

Min Revenue beat(4)-94.43%

Max Revenue beat(4)-18.88%

Revenue beat(8)1

Avg Revenue beat(8)-43.11%

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)76.47%

EPS NQ rev (1m)0%

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)-100%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-47.25%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	408.82
P/S	56.29
P/FCF	N/A
P/OCF	N/A
P/B	35.7
P/tB	35.7
EV/EBITDA	N/A

EPS(TTM)-0.09

EYN/A

EPS(NY)0.01

Fwd EY0.24%

FCF(TTM)-0.04

FCFYN/A

OCF(TTM)-0.04

OCFYN/A

SpS0.07

BVpS0.12

TBVpS0.12

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-68.41%
ROE	-72.87%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	19.51%
FCFM	N/A

ROA(3y)-76.82%

ROA(5y)-101.61%

ROE(3y)-104.1%

ROE(5y)-119.8%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y12.68%

GM growth 5YN/A

F-Score3

Asset Turnover0.6

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	16.35
Quick Ratio	9.39
Altman-Z	343.88

F-Score3

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-22.04%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-190.1%

EPS Next Y-42.86%

EPS Next 2Y46.39%

EPS Next 3Y39.49%

EPS Next 5YN/A

Revenue 1Y (TTM)-7.79%

Revenue growth 3Y-18.13%

Revenue growth 5YN/A

Sales Q2Q%-22.37%

Revenue Next Year71.43%

Revenue Next 2Y155.65%

Revenue Next 3Y104.65%

Revenue Next 5YN/A

EBIT growth 1Y-21.05%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year46.15%

EBIT Next 3Y44.23%

EBIT Next 5YN/A

FCF growth 1Y-31.14%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-31.14%

OCF growth 3YN/A

OCF growth 5YN/A

NEOVOLTA INC (NEOV) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens